New Immunotherapy Strategy Gives Lung Cancer Patients a Fighting Chance
Lung cancer patients may soon have a powerful new weapon in their arsenal. Researchers highlight the immunotherapy approach that could dramatically improve survival rates for those battling this deadly disease.1 This innovative treatment strategy is gaining traction in the medical community. Early trials have shown a significant reduction in cancer recurrence and death rates. But could this be the breakthrough patients and their families have been desperately waiting for? A One-Two Punch against Cancer The new approach combines immunotherapy with traditional chemotherapy, delivering a potent one-two punch to lung cancer cells. Patients receive immunotherapy drugs along with chemotherapy before surgery …










